Introduction: COVID-19 is an
infectious disease that has been causing a global pandemic since 2019. Although
clinical forms are generally less severe in children than in adults, children
nevertheless present polymorphous clinical forms and severe cases that can lead
to death. Objective: To describe the clinical presentations found in the
different waves of COVID-19, and to highlight the different factors of
severity. Materials and Methods: We conducted a cross-sectional study
with retrospective and prospective data collection which lasted 7 months (from
November 2021 to June 2022) and covered a study period from 6 March 2020 to 22 June 2022, i.e. 27 months. All patients aged 0 to 18 years, suspected of
having COVID-19, confirmed by real-time RT-PCR or an antigenic Rapid Diagnostic
Test or antibody were included. These patients were to be managed in the Mother
and Child Centre of the Chantal Biya Foundation, as well as in the Specialised
Centre for the Management of COVID patients, annex number II of the Yaoundé
Central Hospital. The results were analysed using IBM SPSS.23 software. Results: We included 163 patients in our study. No paediatric patients were
registered during the 3rdwave. The mean age of the patients in the study population was 13 ± 5
years with extremes from 15 days to 18 years. We had a female predominance with
a sex ratio of 0.83. The most common comorbidity was asthma. The first wave
presented mainly with respiratory symptoms such as dry cough and signs of
respiratory distress. The second wave presented mainly with digestive symptoms
such as diarrhoea, abdominal pain and vomiting. The fourth wave presented with
ENT signs such as sore throat, and rhinorrhea. Factors associated with
References
[1]
Helmy, Y.A., Fawzy, M., Elaswad, A., et al. (2020) The COVID-19 Pandemic: A Comprehensive Review of Taxonomy, Genetics, Epidemiology, Diagnosis, Treatment, and Control. Journal of Clinical Medicine, 9, 1225.
https://doi.org/10.3390/jcm9041225
[2]
Claude-Audrey, M., et al. (2022) Prevalence of COVID-19 in a Group of Children from the Nkolndongo Health District (Yaounde). Health, 23, 61-63.
https://www.researchgate.net/publication/357673066_Prevalence_of_COVID-19in_a_group_of_children_from_the_Nkolndongo_Health_DistrictYaounde
[3]
University of Pittsburgh (2022, January 19) Children in Sub-Saharan Africa Dying of COVID-19 at a Higher Rate than Others, Study Finds. ScienceDaily.
https://www.sciencedaily.com/releases/2022/01/220119121439.htm
[4]
Camara, E., Barry, I.K., Diallo, F.B., et al. (2020) Profil épidémiologique et clinique des enfants atteints de la maladie à coronavirus (COVID-19) au Centre de Traitement des Epidémies et Prévention des Infections (CTEPI) du CHU de Donka à Conakry. The Pan African Medical Journal, 37, 363.
https://doi.org/10.11604/pamj.2020.37.363.26211
[5]
Butt, A.A., Dargham, S.R., Loka, S., et al. (2022) COVID-19 Disease Severity in Children Infected with the Omicron Variant. Clinical Infectious Diseases, ciac275.
https://doi.org/10.7189/jogh.12.05032
[6]
De Wilde, A.H., Snijder, E.J., Kikkert, M. and van Hemert, M.J. (2017) Host Factors in Coronavirus Replication. Current Topics in Microbiology and Immunology, 419, 1-42. https://doi.org/10.1007/82_2017_25
[7]
Patel, N.A. (2020) Pediatric COVID-19: Systematic Review of the Literature. American Journal of Otolaryngology, 41, Article ID: 102573.
https://doi.org/10.1016/j.amjoto.2020.102573
[8]
Meyer, M., Holfter, A., Ruebsteck, E., et al. (2021) The Alpha Variant (B.1.1.7) of SARS-CoV-2 in Children: First Experience from 3544 Nucleic Acid Amplification Tests in a Cohort of Children in Germany. Viruses, 13, 1600.
https://doi.org/10.3390/v13081600
[9]
Zhang, H., Li, H.B., Lyu, J.R., et al. (2020) Specific ACE2 Expression in Small Intestinal Enterocytes May Cause Gastrointestinal Symptoms and Injury after 2019-nCoV Infection. International Journal of Infectious Diseases, 96, 19-24.
https://doi.org/10.1016/j.ijid.2020.04.027
[10]
Radia, T., Williams, N., Agrawal, P., et al. (2021) Multi-System Inflammatory Syndrome in Children & Adolescents (MIS-C): A Systematic Review of Clinical Features and Presentation. Paediatric Respiratory Reviews, 38, 51-57.
https://doi.org/10.1016/j.prrv.2020.08.001
[11]
Cloete, J., Kruger, A., Masha, M., et al. (2022) Paediatric Hospitalisations Due to COVID-19 during the First SARS-CoV-2 Omicron (B.1.1.529) Variant Wave in South Africa: A Multicentre Observational Study. The Lancet Child & Adolescent Health, 6, 294-302. https://doi.org/10.1016/S2352-4642(22)00027-X
[12]
Ketfi, A., Touahri, R., Chabati, O., et al. (2021) Facteurs de sévérité chez les patients Algériens hospitalisés pour COVID-19. La Tunisie Médicale, 99, 734-743.
[13]
Graff, K., Smith, C., Silveira, L., et al. (2021) Risk Factors for Severe COVID-19 in Children. The Pediatric Infectious Disease Journal, 40, e137.
https://doi.org/10.1097/INF.0000000000003043
[14]
Funk, A.L., Florin, T.A., Kuppermann, N., et al. (2022) Outcomes of SARS-CoV-2-Positive Youths Tested in Emergency Departments: The Global Pern-Covid-19 Study. JAMA Network Open, 5, e2142322.
[15]
Centre de coodination des opérations d’urgences de Santé publique (2022) Rapport Situation Covid-19 Cameroun No. 116.
https://www.ccousp.cm/download/rapport-situation-covid-19-cameroun-n116